McGill University Health Centre (MUHC) news
Major Study Will Test Best Ways to Lower Risk of Heart Disease and Stroke in Adults with Type 2 Diabetes
The Royal Victoria Hospital Metabolic Day Center of the McGill University Health Centre (MUHC) is one of 70 clinics in the United States and Canada taking part in a major new study to test three promising approaches to lower the risk of heart disease and stroke in adults with type 2 diabetes.
An international research team, led by Dr. Erwin Schurr and Dr. Thomas Hudson, Scientists at the Research Institute of the McGill University Health Centre, have identified a gene on human chromosome 6 that makes people vulnerable to leprosy. The study will be published in the March 2003 issue of Nature Genetics.
The new intensive care unit (ICU) at the Montreal General Hospital (MGH) site of the McGill University Health Centre (MUHC) has won a prestigious North American architectural design award.
Annually, 1.25 million Americans suffer burns and 6.5 million experience chronic skin ulcers from diseases such as diabetes. So far, treatment options for these individuals have been limited. However, Dr. Andrew Bateman of the Research Institute of the McGill University Health Centre (MUHC) and his collaborators has recently identified a molecule that may be used to treat these wounds.
In an advance illustrating the power of genomic information, an international team of researchers today announced it has identified a gene that causes Leigh Syndrome, French Canadian type (LSFC), a fatal inherited disorder affecting 1 in 2000 live births each year in the Saguenay-Lac St Jean region of Quebec.
Investigators at the University of Calgary and McGill University have identified genes that underlie two severe diseases of vitamin B12 metabolism. The two diseases, known as the cblA and cblB forms of methylmalonic aciduria, may produce brain damage, mental retardation and even death if not detected in infancy or early childhood.
Juvenile Diabetes Research Foundation Launches Centre For Insulin Secreting Cell Replacement in Montreal
Research to find a viable cure for juvenile diabetes, also known as type 1 diabetes, received a boost today with the launch of the Juvenile Diabetes Research Foundation (JDRF) Centre for Beta Cell Replacement at McGill University and Université de Montréal.
A study published in the November issue of Nature Genetics by investigators from the Research Institute of the McGill University Health Centre (MUHC) identifies a gene that underlies a neurological disorder affecting the brain and spinal cord.
The McGill University Health Centre (MUHC) announced today that, subject to approvals from the Government of Quebec and the City of Montreal, it is planning to dig up contaminated soil on the Glen site next year and transport it to sites licensed by the Quebec Ministry of the Environment.
Novartis Pharmaceuticals Canada Inc. announced today that it is contributing $1,000,000 to Canada's largest osteoporosis study, which is being directed by researchers from the Research Institute of the McGill University Health Centre.
Despite the successes of drug treatments for HIV/AIDS during the last decade, research suggests that a new battle against this deadly disease has opened up.
According to a report prepared by Daniel Arbour & Associés and released today by The McGill University Health Centre (MUHC), the building of a modern health science facility at Glen Yard will result in positive economic benefits for the boroughs of Notre-Dame-de-Grâce/Côte-des- Neiges, the Sud Ouest and Westmount.
Alberta Brothers on cross-country roller-skiing trek To stop at Montreal's Royal Victoria Hospital (MUHC)
Two brothers from Camrose, Alberta will be rolling into Montreal on THURSDAY, JULY 18, as they rollerski the 6,245 kilometers from Edmonton to St. John's, Newfoundland in an effort to thank Canada's unsung heroes - families who have donated a family member's organs and tissue so that others may live.